NGVT Ingevity Corp

8-K Current Report

Filed: February 23, 2026

Health Care

Chemicals & Allied Products

Ingevity Corp (NGVT) 8-K current report filed with SEC EDGAR on February 23, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Jean S. Blackwell not standing for re-election at 2026 Annual Meeting; departure voluntary, no disagreement with company
• Daniel F. Sansone also departing per mandatory retirement age policy in corporate governance guidelines

+2 more insights

Other Ingevity Corp 8-K Filings

8-K Feb 25, 2026

Get deeper insights on Ingevity Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.